The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed at $2.62 in the last session, down -1.13% from day before closing price of $2.65. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 0.73 million shares were traded. BDTX stock price reached its highest trading level at $2.685 during the session, while it also had its lowest trading level at $2.59.
Ratios:
We take a closer look at BDTX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.99. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 149274256 and an Enterprise Value of 33441272. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.13 while its Price-to-Book (P/B) ratio in mrq is 1.18. Its current Enterprise Value per Revenue stands at 0.478 whereas that against EBITDA is 2.208.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.41, which has changed by 0.1324786 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -29.53%, while the 200-Day Moving Average is calculated to be -3.40%.
Shares Statistics:
According to the various share statistics, BDTX traded on average about 1.23M shares per day over the past 3-months and 2348200 shares per day over the past 10 days. A total of 56.94M shares are outstanding, with a floating share count of 44.76M. Insiders hold about 21.44% of the company’s shares, while institutions hold 58.80% stake in the company. Shares short for BDTX as of 1764288000 were 6123148 with a Short Ratio of 5.00, compared to 1761868800 on 6174621. Therefore, it implies a Short% of Shares Outstanding of 6123148 and a Short% of Float of 15.43.
Earnings Estimates
Currently, 6.0 analysts are dedicated to thoroughly evaluating and rating the performance of Black Diamond Therapeutics Inc (BDTX) in the stock market.The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.47 and $0.34 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.19 and -$0.83.
